Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Docetaxel resistance mechanisms
View:
Post by jeffm34 on Sep 17, 2021 11:38am

Docetaxel resistance mechanisms

https://www.sciencedirect.com/science/article/pii/S0753332221006065


The article talks about EMT- mediated metastasis. I think there is a link with the Sortilin receptor and Progranulin. 

"In addition, we have observed an increase in protein expression of the transcription factors SNAIL (SNAI2) and SLUG (SNAI1) in progranulin-treated breast cancer cell lines (Additional file 2) suggesting that progranulin also increase epithelial-mesenchymal transition (EMT) features of breast cancer cells."
 

Also from the original article are suggested ways to overcome docetaxel resistance. 

" The final strategy is brining bioengineering to the help of biology. To date, different kinds of nanocarriers have been developed for delivery of DTX in cancer therapy and enhancing its intracellular accumulation"

Comment by Wino115 on Sep 17, 2021 11:54am
Nice find -- that's a great endorsement on two fronts.  One, it once again documents how powerful taxanes are in stopping cancer cell --so we know this is a toxin the industry see's as highly effective if it can get in the tumor.  Second, TH1902 is one of the three bioengineering methods needed to increase the effectiveness of the drug around resistance --using nanotechnology ...more  
Comment by jeffm34 on Sep 17, 2021 12:29pm
The other effect may be on Progranulin which binds to Sortilin.  " Progranulin induces metastasis in breast cancer models"
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities